Neuroprogression and illness trajectories in bipolar disorder

References

• Merikangas KR, Akiskal HS, Angst J, et al. Lifetime and 12-month prevalence of bipolar spectrum disorder in the National comorbidity survey replication. Arch Gen Psychiatry. 2007;64:543–552.
   PubMed Web of Science ®Google Scholar
• Nordentoft M, Mortensen PB, Pedersen CB. Absolute risk of suicide after first hospital contact in mental disorder. Arch Gen Psychiatry. 2011;68:1058–1064.
   PubMed Web of Science ®Google Scholar
• Samalin L, De Chazeron I, Vieta E, et al. Residual symptoms and specific functional impairments in euthymic patients with bipolar disorder. Bipolar Disord. 2016;18:164–173.
   PubMed Web of Science ®Google Scholar
• Reinares M, Papachristou E, Harvey P, et al. Towards a clinical staging for bipolar disorder: defining patient subtypes based on functional outcome. J Affect Disord. 2013;144:65–71.
   PubMed Web of Science ®Google Scholar
• Rosa AR, Magalhães PVS, Czepielewski L, et al. Clinical staging in bipolar disorder: focus on cognition and functioning. J Clin Psychiatry. 2014;75:e450–6.
   PubMed Web of Science ®Google Scholar
• Abé C, Ekman C-J, Sellgren C, et al. Manic episodes are related to changes in frontal cortex: a longitudinal neuroimaging study of bipolar disorder 1. Brain. 2015;138(pt 11):3440–3448. doi:10.1093/brain/awv266.
   PubMed Web of Science ®Google Scholar
• Mwangi B, Wu M-J, Cao B, et al. Individualized prediction and clinical staging of bipolar disorders using neuroanatomical biomarkers. Biol Psychiatry Cogn Neurosci Neuroimaging. 2016;1:186–194.
   PubMedGoogle Scholar
• Cao B, Passos IC, Mwangi B, et al. Hippocampal volume and verbal memory performance in late-stage bipolar disorder. J Psychiatr Res. 2016;73:102–107.
   PubMed Web of Science ®Google Scholar
• Lavagnino L, Cao B, Mwangi B, et al. Changes in the corpus callosum in women with late-stage bipolar disorder. Acta Psychiatr Scand. 2015;131:458–464.
   PubMed Web of Science ®Google Scholar
• Strakowski SM, DelBello MP, Zimmerman ME, et al. Ventricular and periventricular structural volumes in first- versus multiple-episode bipolar disorder. Am J Psychiatry. 2002;159:1841–1847.
   PubMed Web of Science ®Google Scholar
• Passos IC, Mwangi B, Vieta E, et al. Areas of controversy in neuroprogression in bipolar disorder. Acta Psychiatr Scand. 2016;134:91–103.
   PubMed Web of Science ®Google Scholar
• Wollenhaupt-Aguiar B, Pfaffenseller B, De Saraiva Chagas V, et al. Reduced neurite density in neuronal cell cultures exposed to serum of patients with bipolar disorder. Int J Neuropsychopharmacol. 2016. pii: pyw051. doi:10.1093/ijnp/pyw051.
   PubMed Web of Science ®Google Scholar
• Rajkowska G. Cell pathology in bipolar disorder. Bipolar Disord. 2002;4:105–116.
   PubMed Web of Science ®Google Scholar
• Kapczinski F, Dal-Pizzol F, Teixeira AL, et al. A systemic toxicity index developed to assess peripheral changes in mood episodes. Mol Psychiatry. 2010;15:784–786.
   PubMed Web of Science ®Google Scholar
• Kauer-Sant’Anna M, Kapczinski F, Andreazza AC, et al. Brain-derived neurotrophic factor and inflammatory markers in patients with early- vs. late-stage bipolar disorder. Int J Neuropsychopharmacol. 2009;12:447–458.
   PubMed Web of Science ®Google Scholar
• Andreazza AC, Kauer-Sant’anna M, Frey BN, et al. Oxidative stress markers in bipolar disorder: a meta-analysis. J Affect Disord. 2008;111:135–144.
   PubMed Web of Science ®Google Scholar
• Andreazza AC, Kapczinski F, Kauer-Sant’Anna M, et al. 3-Nitrotyrosine and glutathione antioxidant system in patients in the early and late stages of bipolar disorder. J Psychiatry Neurosci. 2009;34:263–271.
   PubMed Web of Science ®Google Scholar
• Panizzutti B, Gubert C, Schuh AL, et al. Increased serum levels of eotaxin/CCL11 in late-stage patients with bipolar disorder: an accelerated aging biomarker? J Affect Disord. 2015;182:64–69.
   PubMed Web of Science ®Google Scholar
• Patel JP, Frey BN. Disruption in the blood-brain barrier: the missing link between brain and body inflammation in bipolar disorder? Neural Plast. 2015;2015:708306.
   PubMed Web of Science ®Google Scholar
• Haarman BCMB, Riemersma-Van Der Lek RF, De Groot JC, et al. Neuroinflammation in bipolar disorder - A [(11)C]-(R)-PK11195 positron emission tomography study. Brain Behav Immun. 2014;40:244–251.
   PubMed Web of Science ®Google Scholar
• Stertz L, Fries GR, Rosa AR, et al. Damage-associated molecular patterns and immune activation in bipolar disorder. Acta Psychiatr Scand. 2015;132:211–217.
   PubMed Web of Science ®Google Scholar
• Jounai N, Kobiyama K, Takeshita F, et al. Recognition of damage-associated molecular patterns related to nucleic acids during inflammation and vaccination. Front Cell Infect Microbiol. 2012;2:168.
   PubMedGoogle Scholar
• Pfaffenseller B, Da Silva Magalhães PV, De Bastiani MA, et al. Differential expression of transcriptional regulatory units in the prefrontal cortex of patients with bipolar disorder: potential role of early growth response gene 3. Transl Psychiatry. 2016;6:e805.
   PubMed Web of Science ®Google Scholar
• Hibar DP, Westlye LT, Van Erp TGM, et al. Subcortical volumetric abnormalities in bipolar disorder. Mol Psychiatry. 2016;21:1460–1466.
   Web of Science ®Google Scholar
• Lin A, Reniers RLEP, Wood SJ. Clinical staging in severe mental disorder: evidence from neurocognition and neuroimaging. Br J Psychiatry Suppl. 2013;54:s11–7.
   PubMedGoogle Scholar
• Gildengers AG, Chung K-H, Huang S-H, et al. Neuroprogressive effects of lifetime illness duration in older adults with bipolar disorder. Bipolar Disord. 2014;16:617–623.
   PubMed Web of Science ®Google Scholar
• Vita A, De Peri L, Sacchetti E. Gray matter, white matter, brain, and intracranial volumes in first-episode bipolar disorder: a meta-analysis of magnetic resonance imaging studies. Bipolar Disord. 2009;11:807–814.
   PubMed Web of Science ®Google Scholar
• Mills NP, Delbello MP, Adler CM, et al. MRI analysis of cerebellar vermal abnormalities in bipolar disorder. Am J Psychiatry. 2005;162:1530–1533.
   PubMed Web of Science ®Google Scholar
• Monkul ES, Hatch JP, Sassi RB, et al. MRI study of the cerebellum in young bipolar patients. Prog Neuropsychopharmacol Biol Psychiatry. 2008;32:1048–1056.
   PubMed Web of Science ®Google Scholar
• Bo C, Bauer IE, Sharma AN, et al. Reduced hippocampus volume and memory performance in bipolar disorder patients carrying the BDNF val66met met allele. J Affect Disord. 2016;198:198–205.
   PubMed Web of Science ®Google Scholar
• Rao JS, Harry GJ, Rapoport SI, et al. Increased excitotoxicity and neuroinflammatory markers in postmortem frontal cortex from bipolar disorder patients. Mol Psychiatry. 2010;15:384–392.
   PubMed Web of Science ®Google Scholar
• Berk M, Kapczinski F, Andreazza AC, et al. Pathways underlying neuroprogression in bipolar disorder: focus on inflammation, oxidative stress and neurotrophic factors. Neurosci Biobehav Rev. 2011;35:804–817.
   PubMed Web of Science ®Google Scholar
• Kim H-W, Rapoport SI, Rao JS. Altered expression of apoptotic factors and synaptic markers in postmortem brain from bipolar disorder patients. Neurobiol Dis. 2010;37:596–603.
   PubMed Web of Science ®Google Scholar
• Tohen M, Hennen J, Zarate CM, et al. Two-year syndromal and functional recovery in 219 cases of first-episode major affective disorder with psychotic features. Am J Psychiatry. 2000;157:220–228.
   PubMed Web of Science ®Google Scholar
• Rosa AR, González-Ortega I, González-Pinto A, et al. One-year psychosocial functioning in patients in the early vs. late stage of bipolar disorder. Acta Psychiatr Scand. 2012;125:335–341.
   PubMed Web of Science ®Google Scholar
• Wu M-J, Passos IC, Bauer IE, et al. Individualized identification of euthymic bipolar disorder using the Cambridge Neuropsychological Test Automated Battery (CANTAB) and machine learning. J Affect Disord. 2000;157:220–228.
   Google Scholar
• Bourne C, Aydemir Ö, Balanzá-Martínez V, et al. Neuropsychological testing of cognitive impairment in euthymic bipolar disorder: an individual patient data meta-analysis. Acta Psychiatr Scand. 2013;128:149–162.
   PubMed Web of Science ®Google Scholar
• Lolich M, Holtzman JN, Rago CM, et al. Neuroprogression and cognition in bipolar disorders: a systematic review of cognitive performance in euthymic patients. Vertex. 2015;26:265–275.
   PubMedGoogle Scholar
• Ratheesh A, Lin A, Nelson B, et al. Neurocognitive functioning in the prodrome of mania–an exploratory study. J Affect Disord. 2013;147:441–445.
   PubMed Web of Science ®Google Scholar
• Bora E, Yucel M, Pantelis C. Cognitive endophenotypes of bipolar disorder: a meta-analysis of neuropsychological deficits in euthymic patients and their first-degree relatives. J Affect Disord. 2009;113:1–20.
   PubMed Web of Science ®Google Scholar
• Martínez-Arán A, Vieta E, Reinares M, et al. Cognitive function across manic or hypomanic, depressed, and euthymic states in bipolar disorder. Am J Psychiatry. 2004;161:262–270.
   PubMed Web of Science ®Google Scholar
• Kozicky J-M, Torres IJ, Silveira LE, et al. Cognitive change in the year after a first manic episode: association between clinical outcome and cognitive performance early in the course of bipolar I disorder. J Clin Psychiatry. 2014;75:e587–93.
   PubMed Web of Science ®Google Scholar
• Gildengers AG, Mulsant BH, Begley A, et al. The longitudinal course of cognition in older adults with bipolar disorder. Bipolar Disord. 2009;11:744–752.
   PubMed Web of Science ®Google Scholar
• Santos JL, Aparicio A, Bagney A, et al. A five-year follow-up study of neurocognitive functioning in bipolar disorder. Bipolar Disord. 2014;16:722–731.
   PubMed Web of Science ®Google Scholar
• Martino DJ, Strejilevich SA, Marengo E, et al. Relationship between neurocognitive functioning and episode recurrences in bipolar disorder. J Affect Disord. 2013;147:345–351.
   PubMed Web of Science ®Google Scholar
• Gildengers AG, Chisholm D, Butters MA, et al. Two-year course of cognitive function and instrumental activities of daily living in older adults with bipolar disorder: evidence for neuroprogression? Psychol Med. 2013;43:801–811.
   PubMed Web of Science ®Google Scholar
• Samamé C, Martino DJ, Strejilevich SA. Longitudinal course of cognitive deficits in bipolar disorder: a meta-analytic study. J Affect Disord. 2014;164:130–138.
   PubMed Web of Science ®Google Scholar
• Da Costa SC, Passos IC, Lowri C, et al. 2015. Refractory bipolar disorder and neuroprogression. Prog Neuropsychopharmacol Biol Psychiatry. 2016;70:103–110.
   PubMed Web of Science ®Google Scholar
• Scott J, Paykel E, Morriss R, et al. Cognitive-behavioural therapy for severe and recurrent bipolar disorders: randomised controlled trial. Br J Psychiatry. 2006;188:313–320.
   PubMed Web of Science ®Google Scholar
• Swann AC, Bowden CL, Calabrese JR, et al. Differential effect of number of previous episodes of affective disorder on response to lithium or divalproex in acute mania. Am J Psychiatry. 1999;156:321–323.
   PubMed Web of Science ®Google Scholar
• Reinares M, Colom F, Rosa AR, et al. The impact of staging bipolar disorder on treatment outcome of family psychoeducation. J Affect Disord. 2010;123:81–86.
   PubMed Web of Science ®Google Scholar
• Berk M, Brnabic A, Dodd S, et al. Does stage of illness impact treatment response in bipolar disorder? empirical treatment data and their implication for the staging model and early intervention. Bipolar Disord. 2011;13:87–98.
   PubMed Web of Science ®Google Scholar
• Goi PD, Bücker J, Vianna-Sulzbach M, et al. Pharmacological treatment and staging in bipolar disorder: evidence from clinical practice. Rev Bras Psiquiatr. 1999;37:121–125.
   Google Scholar
• Obrocea GV, Dunn RM, Frye MA, et al. Clinical predictors of response to lamotrigine and gabapentin monotherapy in refractory affective disorders. Biol Psychiatry. 2002;51:253–260.
   PubMed Web of Science ®Google Scholar
• Torrent C, Bonnin C, Del M, et al. Efficacy of functional remediation in bipolar disorder: a multicenter randomized controlled study. Am J Psychiatry. 2013;170:852–859.
   PubMed Web of Science ®Google Scholar
• Bonnin CM, Torrent C, Arango C, et al. Functional remediation in bipolar disorder: 1-year follow-up of neurocognitive and functional outcome. Br J Psychiatry. 2016;208:87–93.
   PubMed Web of Science ®Google Scholar
• Bonnin CM, Reinares M, Martínez-Arán A, et al. Effects of functional remediation on neurocognitively impaired bipolar patients: enhancement of verbal memory. Psychol Med. 2016;46:291–301.
   PubMed Web of Science ®Google Scholar
• Li X-B, Tang Y-L, Wang C-Y, et al. Clozapine for treatment-resistant bipolar disorder: a systematic review. Bipolar Disord. 2014;17(3):235–247.
   Web of Science ®Google Scholar
• Gitlin M. Treatment-resistant bipolar disorder. Mol Psychiatry. 2006;11:763–770.
   PubMed Web of Science ®Google Scholar
• Poon SH, Sim K, Sum MY, et al. Evidence-based options for treatment-resistant adult bipolar disorder patients. Bipolar Disord. 2012;14:573–584.
   PubMed Web of Science ®Google Scholar
• Chang JS, Ha K-S, Young Lee K, et al. The effects of long-term clozapine add-on therapy on the rehospitalization rate and the mood polarity patterns in bipolar disorders. J Clin Psychiatry. 2006;67:461–467.
   PubMed Web of Science ®Google Scholar
• Wu C-S, Wang S-C, Liu S-K. Clozapine use reduced psychiatric hospitalization and emergency room visits in patients with bipolar disorder independent of improved treatment regularity in a three-year follow-up period. Bipolar Disord. 2015;17:415–423.
   PubMed Web of Science ®Google Scholar
• Rosenblat JD, Kakar R, Berk M, et al. Anti-inflammatory agents in the treatment of bipolar depression: a systematic review and meta-analysis. Bipolar Disord. 2016;18:89–101.
   PubMed Web of Science ®Google Scholar
• Passos IC, Jansen K, Cardoso T, et al. Clinical outcomes associated with comorbid posttraumatic stress disorder among patients with bipolar disorder. J Clin Psychiatry. 2016;77:e555–60.
   PubMed Web of Science ®Google Scholar
• Leverich GS, Post RM. Course of bipolar illness after history of childhood trauma. Lancet. 2006;367:1040–1042.
   PubMed Web of Science ®Google Scholar
• Fernandes BS, Molendijk ML, Köhler CA, et al. Peripheral brain-derived neurotrophic factor (BDNF) as a biomarker in bipolar disorder: a meta-analysis of 52 studies. BMC Med. 2015;13:289.
   PubMed Web of Science ®Google Scholar
• Frank E, Nimgaonkar VL, Phillips ML, et al. All the world’s a (clinical) stage: rethinking bipolar disorder from a longitudinal perspective. Mol Psychiatry. 2015;20:23–31.
   PubMed Web of Science ®Google Scholar
• Passos IC, Mwangi B, Kapczinski F. Big data analytics and machine learning: 2015 and beyond. Lancet Psychiatry. 2016;3:13–15.
   PubMed Web of Science ®Google Scholar
• Sen S, Duman R, Sanacora G. Serum brain-derived neurotrophic factor, depression, and antidepressant medications: meta-analyses and implications. Biol Psychiatry. 2008;64:527–532.
   PubMed Web of Science ®Google Scholar
• Dowlati Y, Herrmann N, Swardfager W, et al. A meta-analysis of cytokines in major depression. Biol Psychiatry. 2010;67:446–457.
   PubMed Web of Science ®Google Scholar
• Ng F, Berk M, Dean O, et al. Oxidative stress in psychiatric disorders: evidence base and therapeutic implications. Int J Neuropsychopharmacol. 2008;11:851–876.
   PubMed Web of Science ®Google Scholar
• Khoury MJ, Ioannidis JPA. Medicine. Big Data Meets Public Health Science. 2014;346:1054–1055.
   Google Scholar
• Mwangi B, Ebmeier KP, Matthews K, et al. Multi-centre diagnostic classification of individual structural neuroimaging scans from patients with major depressive disorder. Brain. 2012;135:1508–1521.
   PubMed Web of Science ®Google Scholar
• Iniesta R, Stahl D, McGuffin P. Machine learning, statistical learning and the future of biological research in psychiatry. Psychol Med. 2016;46:2455–2465.
   PubMed Web of Science ®Google Scholar
• Passos IC, Mwangi B, Kapczinski F. Big data analytics and machine learning in psychiatry. Lancet Psychiatry. 2016;3:13–15.
   PubMed Web of Science ®Google Scholar
• Wu MJ, Mwangi B, Bauer IE, et al. Identification and individualized prediction of clinical phenotypes in bipolar disorders using neurocognitive data, neuroimaging scans and machine learning. Neuroimage. 2016. doi:10.1016/j.neuroimage.2016.02.016. [Epub ahead of print].
   Web of Science ®Google Scholar
• Passos IC, Mwangi B, Cao B, et al. Identifying a clinical signature of suicidality among patients with mood disorders: a pilot study using a machine learning approach. J Affect Disord. 2016;193:13–15.
   Web of Science ®Google Scholar
• Eshaghi A, Riyahi-Alam S, Saeedi R, et al. Classification algorithms with multi-modal data fusion could accurately distinguish neuromyelitis optica from multiple sclerosis. NeuroImage Clin. 2015;7:306–314.
   PubMed Web of Science ®Google Scholar
• Zhang D, Wang Y, Zhou L, et al. Multimodal classification of Alzheimer’s disease and mild cognitive impairment. Neuroimage. 2011;55:856–867.
   PubMed Web of Science ®Google Scholar
• Redlich R, Almeida JJR, Grotegerd D, et al. Brain morphometric biomarkers distinguishing unipolar and bipolar depression. A voxel-based morphometry-pattern classification approach. JAMA Psychiatry. 2014;71:1222–1230.
   PubMed Web of Science ®Google Scholar
• Mwangi B, Spiker D, Zunta-Soares GB, et al. Prediction of pediatric bipolar disorder using neuroanatomical signatures of the amygdala. Bipolar Disord. 2014;16:713–721.
   PubMed Web of Science ®Google Scholar